Astrana Health (NASDAQ:ASTH) Sets New 12-Month Low Following Analyst Downgrade

Astrana Health, Inc. (NASDAQ:ASTH) hit a new 52-week low during mid-day trading on Monday after Truist Financial lowered their price target on the stock from $59.00 to $50.00. Truist Financial currently has a buy rating on the stock. Astrana Health traded as low as $29.08 and last traded at $29.42, with a volume of 13470 shares. The stock had previously closed at $29.48.

A number of other analysts have also recently commented on the company. TD Cowen began coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. Robert W. Baird upped their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. BTIG Research upped their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Finally, KeyCorp began coverage on shares of Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $63.67.

Institutional Investors Weigh In On Astrana Health

Institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC purchased a new stake in shares of Astrana Health during the third quarter worth about $34,000. Nisa Investment Advisors LLC bought a new stake in Astrana Health during the third quarter worth approximately $35,000. KBC Group NV purchased a new stake in Astrana Health during the 3rd quarter valued at $70,000. Quarry LP bought a new stake in shares of Astrana Health in the 3rd quarter worth about $77,000. Finally, Quest Partners LLC bought a new stake in Astrana Health in the third quarter worth about $133,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Trading Up 2.7 %

The stock has a fifty day moving average of $39.55 and a 200-day moving average of $47.05. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market cap of $1.70 billion, a PE ratio of 23.29, a PEG ratio of 1.80 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting the consensus estimate of $0.33. The company had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period last year, the business posted $0.47 EPS. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.